Chulwon Kim

3.0k total citations
53 papers, 2.6k citations indexed

About

Chulwon Kim is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Chulwon Kim has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Chulwon Kim's work include Cytokine Signaling Pathways and Interactions (19 papers), Natural product bioactivities and synthesis (10 papers) and Bioactive Compounds and Antitumor Agents (9 papers). Chulwon Kim is often cited by papers focused on Cytokine Signaling Pathways and Interactions (19 papers), Natural product bioactivities and synthesis (10 papers) and Bioactive Compounds and Antitumor Agents (9 papers). Chulwon Kim collaborates with scholars based in South Korea, Singapore and United States. Chulwon Kim's co-authors include Kwang Seok Ahn, Gautam Sethi, Jong Hyun Lee, Seok‐Geun Lee, Jae‐Young Um, Dongwoo Nam, Woong Mo Yang, Seung Ho Baek, Sung‐Hoon Kim and Alan Prem Kumar and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Chulwon Kim

53 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chulwon Kim South Korea 31 1.6k 749 469 363 359 53 2.6k
Mee‐Hyun Lee South Korea 33 2.4k 1.5× 739 1.0× 546 1.2× 459 1.3× 423 1.2× 130 3.8k
A.R.M. Ruhul Amin United States 28 1.6k 1.0× 608 0.8× 475 1.0× 180 0.5× 308 0.9× 62 3.0k
Benny K.H. Tan Singapore 12 1.2k 0.8× 483 0.6× 260 0.6× 270 0.7× 196 0.5× 16 2.2k
Ji Hoon Jung South Korea 31 1.5k 1.0× 472 0.6× 464 1.0× 234 0.6× 148 0.4× 116 2.6k
Sung‐Gook Cho South Korea 27 1.3k 0.8× 403 0.5× 315 0.7× 165 0.5× 175 0.5× 60 2.2k
Gopalakrishnan Ramakrishnan United States 29 1.5k 1.0× 440 0.6× 385 0.8× 307 0.8× 234 0.7× 64 2.9k
Bum Sang Shim South Korea 26 1.1k 0.7× 383 0.5× 262 0.6× 275 0.8× 149 0.4× 62 1.9k
Jeong‐Hyeon Ko South Korea 22 1.1k 0.7× 475 0.6× 352 0.8× 197 0.5× 240 0.7× 38 2.1k
Eun‐Ryeong Hahm United States 35 1.8k 1.1× 409 0.5× 385 0.8× 193 0.5× 197 0.5× 84 3.2k
Ming‐Ju Hsieh Taiwan 32 1.9k 1.2× 430 0.6× 689 1.5× 231 0.6× 206 0.6× 140 3.0k

Countries citing papers authored by Chulwon Kim

Since Specialization
Citations

This map shows the geographic impact of Chulwon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chulwon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chulwon Kim more than expected).

Fields of papers citing papers by Chulwon Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chulwon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chulwon Kim. The network helps show where Chulwon Kim may publish in the future.

Co-authorship network of co-authors of Chulwon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Chulwon Kim. A scholar is included among the top collaborators of Chulwon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chulwon Kim. Chulwon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Chulwon, Jong Hyun Lee, Arunachalam Chinnathambi, et al.. (2019). Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine. 59. 152907–152907. 63 indexed citations
3.
Kim, Chulwon, Seok‐Geun Lee, Woong Mo Yang, et al.. (2018). Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer Letters. 431. 123–141. 164 indexed citations
4.
Lee, Jong Hyun, Chulwon Kim, Seok‐Geun Lee, et al.. (2018). Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells. Phytomedicine. 40. 165–175. 47 indexed citations
5.
Dai, Xiaoyun, Kwang Seok Ahn, Ling Zhi Wang, et al.. (2016). Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 15(12). 2966–2976. 82 indexed citations
6.
Baek, Seung Ho, Jeong‐Hyeon Ko, Jong Hyun Lee, et al.. (2016). Ginkgolic Acid Inhibits Invasion and Migration and TGF‐β‐Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Journal of Cellular Physiology. 232(2). 346–354. 187 indexed citations
8.
Kim, Chulwon, Seok‐Geun Lee, Jun‐Hee Lee, et al.. (2015). Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM‐5 Cells. Phytotherapy Research. 29(7). 1062–1072. 9 indexed citations
9.
Kim, Chulwon, Jin Ho Kim, Eun Young Oh, et al.. (2015). Blockage of STAT3 Signaling Pathway by Morusin Induces Apoptosis and Inhibits Invasion in Human Pancreatic Tumor Cells. Pancreas. 45(3). 409–419. 35 indexed citations
10.
Lee, Jong Hyun, Chulwon Kim, Sung‐Hoon Kim, Gautam Sethi, & Kwang Seok Ahn. (2015). Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway. Cancer Letters. 360(2). 280–293. 113 indexed citations
11.
13.
Lee, Jong Hyun, Chulwon Kim, Dongwoo Nam, et al.. (2012). Capillarisin inhibits iNOS, COX-2 expression, and proinflammatory cytokines in LPS-induced RAW 264.7 macrophages via the suppression of ERK, JNK, and NF-κB activation. Immunopharmacology and Immunotoxicology. 35(1). 34–42. 55 indexed citations
14.
Kim, Sung‐Moo, Chulwon Kim, Dongwoo Nam, et al.. (2012). Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4. Immunopharmacology and Immunotoxicology. 34(5). 768–778. 42 indexed citations
15.
Lee, Eunjung, Chulwon Kim, Jin-Young Kim, et al.. (2011). Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction ofPatrinia scabiosaefoliathrough suppression of NF-κB activation in RAW 264.7 cells. Immunopharmacology and Immunotoxicology. 34(2). 282–291. 19 indexed citations
16.
Choi, Tae Won, Chulwon Kim, Dongwoo Nam, et al.. (2011). Anti-inflammatory activities ofReynoutria ellipticathrough suppression of mitogen-activated protein kinases and nuclear factor-κB activation pathways. Immunopharmacology and Immunotoxicology. 34(3). 454–464. 18 indexed citations
18.
Kim, Chulwon, et al.. (2009). A study on the profitability and marketing costs of seed potato farming in Bangladesh. Korean Journal of Food Preservation. 16(4). 490–498. 1 indexed citations
19.
Kim, Chulwon, et al.. (2007). A Study on the Activation of National Recreation Forest - Using Importance - Performance Analysis -. International Journal of Tourism Management and Sciences. 21(4). 101–119. 3 indexed citations
20.
Kim, Chulwon, et al.. (2004). Effects of Water Temperature and Salinity on Dietary Feeding of Manila clam(Ruditapes philippinarum). Environmental Biology Research. 22(1). 28–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026